The most effective contract development and manufacturing organizations (CDMOs) help their clients by developing optimal, cost-efficient processes. Since its origins over 50 years ago, BIOVECTRA has […] […]
Read More…
Certificates of analysis (CoAs) are used by materials suppliers to identify the product they are providing to a pharmaceutical manufacturer. They include information such as product name, material grade, batch number, expiration dates, testing dates, information on analytical […] […]
Read More…
Microbial fermentation has its place in the biomanufacturing industry, despite the prevalence of mammalian-based cell culture processes for the production of biologics. However, despite the lower costs and potential for substantial product […] […]
Read More…
Perhaps the biggest supply issue for cell and gene therapies is a lack of reliable sources of GMP-grade plasmid DNA. The supply of pDNA – and, therefore, mRNA – is constrained by both manufacturing issues and short supply of consumables […] […]
Read More…
Two decades ago, the Canadian CDMO BioVectra installed Heather Delage as its director of business development. She was named vice president of business development […] […]
Read More…
Effective and safe APIs provide the necessary element of drugs to treat patients with a variety of health conditions. It is, therefore, crucial that the quality of APIs, along with other ingredients that make up a medicine […] […]
Read More…
Founded in 1970, BIOVECTRA is a CDMO with specialties in microbial fermentation, complex chemistry and biologics. The company is looking to bolster its mRNA manufacturing capability.[…] […]
Read More…
Headquartered in Atlantic Canada, BIOVECTRA is a heavyweight global CDMO with a rich history and relentless focus on adapting to future trends. With an eye on the next generation of pharmaceuticals […] […]
Read More…
BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada. This exciting new capability will result from […] […]
Read More…
The development and production of mRNA therapeutics and vaccines requires expertise in both chemical synthesis and microbial fermentation. […] […]
Read More…